116 related articles for article (PubMed ID: 23542582)
1. Structure-guided engineering of Anticalins with improved binding behavior and biochemical characteristics for application in radio-immuno imaging and/or therapy.
Eggenstein E; Eichinger A; Kim HJ; Skerra A
J Struct Biol; 2014 Feb; 185(2):203-14. PubMed ID: 23542582
[TBL] [Abstract][Full Text] [Related]
2. Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities.
Skerra A
FEBS J; 2008 Jun; 275(11):2677-83. PubMed ID: 18435758
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial design of an Anticalin directed against the extra-domain b for the specific targeting of oncofetal fibronectin.
Gebauer M; Schiefner A; Matschiner G; Skerra A
J Mol Biol; 2013 Feb; 425(4):780-802. PubMed ID: 23238252
[TBL] [Abstract][Full Text] [Related]
4. High-affinity recognition of lanthanide(III) chelate complexes by a reprogrammed human lipocalin 2.
Kim HJ; Eichinger A; Skerra A
J Am Chem Soc; 2009 Mar; 131(10):3565-76. PubMed ID: 19227970
[TBL] [Abstract][Full Text] [Related]
5. Crystallographic analysis of an "anticalin" with tailored specificity for fluorescein reveals high structural plasticity of the lipocalin loop region.
Korndörfer IP; Beste G; Skerra A
Proteins; 2003 Oct; 53(1):121-9. PubMed ID: 12945055
[TBL] [Abstract][Full Text] [Related]
6. A novel type of receptor protein, based on the lipocalin scaffold, with specificity for digoxigenin.
Schlehuber S; Beste G; Skerra A
J Mol Biol; 2000 Apr; 297(5):1105-20. PubMed ID: 10764576
[TBL] [Abstract][Full Text] [Related]
7. Anticalins small engineered binding proteins based on the lipocalin scaffold.
Gebauer M; Skerra A
Methods Enzymol; 2012; 503():157-88. PubMed ID: 22230569
[TBL] [Abstract][Full Text] [Related]
8. The menagerie of human lipocalins: a natural protein scaffold for molecular recognition of physiological compounds.
Schiefner A; Skerra A
Acc Chem Res; 2015 Apr; 48(4):976-85. PubMed ID: 25756749
[TBL] [Abstract][Full Text] [Related]
9. Anticalins: exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins.
Richter A; Eggenstein E; Skerra A
FEBS Lett; 2014 Jan; 588(2):213-8. PubMed ID: 24239535
[TBL] [Abstract][Full Text] [Related]
10. Tuning ligand affinity, specificity, and folding stability of an engineered lipocalin variant -- a so-called 'anticalin' -- using a molecular random approach.
Schlehuber S; Skerra A
Biophys Chem; 2002 May; 96(2-3):213-28. PubMed ID: 12034442
[TBL] [Abstract][Full Text] [Related]
11. High-throughput sorting of an Anticalin library via EspP-mediated functional display on the Escherichia coli cell surface.
Binder U; Matschiner G; Theobald I; Skerra A
J Mol Biol; 2010 Jul; 400(4):783-802. PubMed ID: 20630471
[TBL] [Abstract][Full Text] [Related]
12. Construction of an artificial receptor protein ("anticalin") based on the human apolipoprotein D.
Vogt M; Skerra A
Chembiochem; 2004 Feb; 5(2):191-9. PubMed ID: 14760740
[TBL] [Abstract][Full Text] [Related]
13. Anticalin® proteins: from bench to bedside.
Deuschle FC; Ilyukhina E; Skerra A
Expert Opin Biol Ther; 2021 Apr; 21(4):509-518. PubMed ID: 33074019
[TBL] [Abstract][Full Text] [Related]
14. Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA).
Barinka C; Ptacek J; Richter A; Novakova Z; Morath V; Skerra A
Protein Eng Des Sel; 2016 Mar; 29(3):105-15. PubMed ID: 26802163
[TBL] [Abstract][Full Text] [Related]
15. High-affinity Anticalins with aggregation-blocking activity directed against the Alzheimer β-amyloid peptide.
Rauth S; Hinz D; Börger M; Uhrig M; Mayhaus M; Riemenschneider M; Skerra A
Biochem J; 2016 Jun; 473(11):1563-78. PubMed ID: 27029347
[TBL] [Abstract][Full Text] [Related]
16. Anticalins as alternative binding proteins for therapeutic use.
Skerra A
Curr Opin Mol Ther; 2007 Aug; 9(4):336-44. PubMed ID: 17694446
[TBL] [Abstract][Full Text] [Related]
17. Rational engineering of a fluorescein-binding anticalin for improved ligand affinity.
Vopel S; Mühlbach H; Skerra A
Biol Chem; 2005 Nov; 386(11):1097-104. PubMed ID: 16307475
[TBL] [Abstract][Full Text] [Related]
18. Drastic alterations in the loop structure around colchicine upon complex formation with an engineered lipocalin indicate a conformational selection mechanism.
Jerschke E; Eichinger A; Skerra A
Acta Crystallogr F Struct Biol Commun; 2023 Sep; 79(Pt 9):231-239. PubMed ID: 37584182
[TBL] [Abstract][Full Text] [Related]
19. Structural plasticity in the loop region of engineered lipocalins with novel ligand specificities, so-called Anticalins.
Achatz S; Jarasch A; Skerra A
J Struct Biol X; 2022; 6():100054. PubMed ID: 34988429
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the human odorant binding protein, OBPIIa.
Schiefner A; Freier R; Eichinger A; Skerra A
Proteins; 2015 Jun; 83(6):1180-4. PubMed ID: 25810031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
